Phase ii clinical drugs investigational. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy2

Cell Line, Tumor Esophagogastric Junction

Organisms2

Coxiella Coxiella burnetii

Diseases69

Neoplasms Lung Neoplasms Neutropenia Neoplasm Metastasis Leukopenia Neoplasm Recurrence, Local Carcinoma, Non-Small-Cell Lung Disease Progression Nausea Thrombocytopenia Breast Neoplasms Brain Neoplasms Hematologic Diseases Peritoneal Neoplasms Colorectal Neoplasms Vomiting Ovarian Neoplasms Biliary Tract Neoplasms Stomach Neoplasms Asthenia Melanoma Kidney Neoplasms Carcinoma, Squamous Cell Carcinoma, Renal Cell Liver Neoplasms Sarcoma Carcinoma, Small Cell Head and Neck Neoplasms Pancreatic Neoplasms Urologic Neoplasms Pleural Neoplasms Q Fever Fatigue Diarrhea Mesothelioma Glioblastoma Prostatic Neoplasms Recurrence Carcinoma Lymphoma, Non-Hodgkin Stomatitis Glioma Exanthema Drug-Related Side Effects and Adverse Reactions Fallopian Tube Neoplasms Esophageal Neoplasms Bone Neoplasms Soft Tissue Neoplasms Carcinoma, Transitional Cell Neoplasms, Glandular and Epithelial Rectal Neoplasms Brain Stem Neoplasms Anorexia Anemia Small Cell Lung Carcinoma Drug Eruptions Agranulocytosis Gallbladder Neoplasms Carcinoma, Large Cell Gastrointestinal Diseases Lymphoma, Mantle-Cell Supratentorial Neoplasms Leiomyosarcoma Central Nervous System Neoplasms Gastrointestinal Neoplasms Lymphoma, Follicular Neoplasms, Unknown Primary Astrocytoma Lymphatic Metastasis

Chemicals and Drugs106

Pharmaceutical Preparations P-Glycoprotein Antineoplastic Agents Multidrug Resistance-Associated Proteins Cytochrome P-450 Enzyme System Deoxycytidine Paclitaxel Taxoids Cisplatin Fluorouracil Organoplatinum Compounds Camptothecin Antineoplastic Agents, Phytogenic Carboplatin Antibodies, Monoclonal, Humanized Antimetabolites, Antineoplastic Vinblastine Dacarbazine Quinazolines Leucovorin Antineoplastic Agents, Alkylating Epothilones Benzenesulfonates Tegafur Doxorubicin Phenylurea Compounds Antibodies, Monoclonal Niacinamide NAD(P)H Dehydrogenase (Quinone)Oxonic Acid Etoposide Ifosfamide Epirubicin Cyclophosphamide Estramustine Bridged Compounds Angiogenesis Inhibitors Thalidomide Pyridines Pyrazines NF-E2-Related Factor 2 Glutathione Transferase Vincristine Guanine Anthracyclines Depsipeptides Protein Kinase Inhibitors Antibodies, Monoclonal, Murine-Derived Granulocyte Colony-Stimulating Factor Antibiotics, Antineoplastic Isothiocyanates Pyrroles Boronic Acids Glucuronosyltransferase Nitrogen Mustard Compounds Platinum Compounds Pyrimidines Glucuronides Xenobiotics Indoles Glutamates Drug Combinations Mitoxantrone Prostate-Specific Antigen Benzamides Anticarcinogenic Agents Uracil Tumor Markers, Biological Interferon-alpha Thiocyanates Prednisone Recombinant Proteins Mesna Mitomycin Dioxoles Thiophenes Receptor, Epidermal Growth Factor Placebos Biomarkers, Pharmacological Tetrahydroisoquinolines Vidarabine Phosphate Sulfonamides Drugs, Investigational Piperazines Dexamethasone Platinum Isotretinoin Receptor, erbB-2 Glutathione S-Transferase pi Cancer Vaccines Methotrexate Pyrazoles Piperidines Polyethylene Glycols Antineoplastic Agents, Hormonal Amifostine Trimetrexate Topoisomerase I Inhibitors Bryostatins Cytarabine Pentostatin Farnesyltranstransferase Cladribine Quinolines Carmustine Floxuridine

Analytical, Diagnostic and Therapeutic Techniques and Equipment54

Clinical Trials, Phase II as Topic Drug Design Clinical Trials as Topic Drug Discovery Drug Evaluation, Preclinical Antineoplastic Combined Chemotherapy Protocols Drug Administration Schedule Treatment Outcome Infusions, Intravenous Disease-Free Survival Drug Evaluation Survival Analysis Maximum Tolerated Dose Survival Rate Administration, Oral Clinical Trials, Phase III as Topic Neoplasm Staging Combined Modality Therapy Salvage Therapy Kaplan-Meier Estimate Remission Induction Endpoint Determination Neoadjuvant Therapy Clinical Trials, Phase I as Topic Research Design Feasibility Studies Follow-Up Studies Chemotherapy, Adjuvant Double-Blind Method Area Under Curve Prospective Studies Treatment Failure Prognosis Injections, Subcutaneous Sample Size Injections, Intravenous Chemoradiotherapy Dose Fractionation Randomized Controlled Trials as Topic Radiotherapy, Adjuvant Induction Chemotherapy Pilot Projects Placebos Administration, Intravenous Patient Selection Karnofsky Performance Status Drug Therapy, Combination Multicenter Studies as Topic Probability Palliative Care Infusions, Parenteral Immunotherapy Orchiectomy Metabolic Clearance Rate

Phenomena and Processes14

Drug Resistance, Neoplasm Drug Resistance, Multiple Drug Interactions Drug Resistance Metabolic Detoxication, Phase II Dose-Response Relationship, Drug Maximum Tolerated Dose Time Factors Area Under Curve Metabolic Detoxication, Phase I Metabolic Detoxication, Drug Biotransformation Probability Metabolic Clearance Rate

Disciplines and Occupations4

Drug Design Drug Discovery Research Design Medical Oncology

Anthropology, Education, Sociology and Social Phenomena2

Quality of Life Survival

Technology, Industry, Agriculture2

Drug Industry Polyethylene Glycols

Humanities1

Quality of Life

Information Science4

RxNorm Drug Information Services Terminology as Topic Survival Rate

Health Care25

Drug Information Services Clinical Trials, Phase II as Topic Clinical Trials as Topic Treatment Outcome Disease-Free Survival Survival Analysis Survival Rate Clinical Trials, Phase III as Topic Kaplan-Meier Estimate Clinical Trials, Phase I as Topic Feasibility Studies Follow-Up Studies Double-Blind Method Area Under Curve Prospective Studies Treatment Failure Safety Sample Size Randomized Controlled Trials as Topic Pilot Projects Patient Selection Karnofsky Performance Status Multicenter Studies as Topic Probability Palliative Care

Publication Characteristics1

Clinical Trial, Phase II

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Technology, Industry, Agriculture Humanities Information Science Health Care Publication Characteristics

RxNorm Drug Information Services Pharmaceutical Preparations Clinical Trials, Phase II as Topic Drug Industry Drug Design Clinical Trials as Topic P-Glycoprotein Drug Resistance, Neoplasm Drug Discovery Antineoplastic Agents Drug Resistance, Multiple Terminology as Topic Drug Evaluation, Preclinical Drug Interactions Multidrug Resistance-Associated Proteins Drug Resistance Neoplasms Metabolic Detoxication, Phase II Dose-Response Relationship, Drug Cytochrome P-450 Enzyme System Antineoplastic Combined Chemotherapy Protocols Drug Administration Schedule Treatment Outcome Infusions, Intravenous Deoxycytidine Cell Line, Tumor Disease-Free Survival Paclitaxel Taxoids Drug Evaluation Cisplatin Fluorouracil Survival Analysis Organoplatinum Compounds Camptothecin Maximum Tolerated Dose Antineoplastic Agents, Phytogenic Lung Neoplasms Survival Rate Neutropenia Neoplasm Metastasis Carboplatin Leukopenia Neoplasm Recurrence, Local Antibodies, Monoclonal, Humanized Administration, Oral Clinical Trials, Phase III as Topic Neoplasm Staging Antimetabolites, Antineoplastic Combined Modality Therapy Carcinoma, Non-Small-Cell Lung Salvage Therapy Vinblastine Disease Progression Dacarbazine Nausea Quinazolines Leucovorin Thrombocytopenia Coxiella Antineoplastic Agents, Alkylating Epothilones Benzenesulfonates Tegafur Kaplan-Meier Estimate Doxorubicin Phenylurea Compounds Antibodies, Monoclonal Niacinamide NAD(P)H Dehydrogenase (Quinone)Remission Induction Oxonic Acid Endpoint Determination Etoposide Breast Neoplasms Ifosfamide Brain Neoplasms Neoadjuvant Therapy Clinical Trials, Phase I as Topic Hematologic Diseases Peritoneal Neoplasms Colorectal Neoplasms Epirubicin Time Factors Cyclophosphamide Research Design Vomiting Estramustine Feasibility Studies Ovarian Neoplasms Biliary Tract Neoplasms Stomach Neoplasms Follow-Up Studies Bridged Compounds Asthenia Melanoma Angiogenesis Inhibitors Kidney Neoplasms Thalidomide

No FAQ available that match "phase ii clinical drugs investigational"